Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 36Terminated 9Recruiting 6Withdrawn 4Unknown 4Active not recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Leukemia, Myeloid, Acute 26Colorectal Neoplasms 26Neoplasms 24Neoplasm Metastasis 23Recurrence 22Multiple Myeloma 22Advanced Solid Tumors 19Lymphoma, B-Cell 18Breast Neoplasms 18Lung Neoplasms 14Pancreatic Neoplasms 13Glioblastoma 13Melanoma 12Hematologic Neoplasms 12Carcinoma, Hepatocellular 12Lymphoma 11Glioma 11Brain Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Advanced Solid Tumor 10Prostatic Neoplasms 9Ovarian Neoplasms 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Esophageal Neoplasms 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Dendritic Cell Sarcoma, Interdigitating × Clear all
NCT07443137 2026-05-08

CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

Stanford University

Phase 1 Not yet recruiting
20 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡